{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:17:20Z","timestamp":1789802240436,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"DOI":"10.7759\/cureus.116519","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:27:07Z","timestamp":1789799227000},"source":"Crossref","is-referenced-by-count":0,"title":["A Conservatively Managed Giant Ascending Aortic Aneurysm Presenting With New Atrial Fibrillation and Heart Failure"],"prefix":"10.7759","author":[{"given":"Alyaa","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Behounek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001106","article-title":"ACC\/AHA guideline for the diagnosis and management of aortic disease - a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"146","author":"Isselbacher EM","year":"2022","unstructured":"Isselbacher EM, Preventza O, Hamilton Black J 3rd, et al.. ACC\/AHA guideline for the diagnosis and management of aortic disease - a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022, 146:e334-482. 10.1161\/CIR.0000000000001106","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(02)04147-4","article-title":"Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks","volume":"74","author":"Elefteriades JA","year":"2002","unstructured":"Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg. 2002, 74:1877-1880. 10.1016\/S0003-4975(02)04147-4","journal-title":"Ann Thorac Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.11.2010.3504","article-title":"Giant aneurysm of the ascending aorta","volume":"2011","author":"Srivastava V","year":"2011","unstructured":"Srivastava V, AlHadid K, Saravanan P, Zacharias J, Bittar MN. Giant aneurysm of the ascending aorta. BMJ Case Rep. 2011, 2011:bcr1120103504. 10.1136\/bcr.11.2010.3504","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1730005","article-title":"A case report of giant ascending aortic aneurysm: Role of multimodality imaging","volume":"9","author":"Shah SH","year":"2021","unstructured":"Shah SH, Shah MA, Alganadi AA, Alshehri HZ, Mir MS, Alshammari AM. A case report of giant ascending aortic aneurysm: Role of multimodality imaging. Aorta (Stamford). 2021, 9:106-9. 10.1055\/s-0041-1730005","journal-title":"Aorta (Stamford)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.09.024","article-title":"Digoxin dosing and the risk of toxicity in older adults with CKD","volume":"79","author":"Muanda FT","year":"2022","unstructured":"Muanda FT, Weir MA, Ahmadi F, McArthur E, Sontrop JM, Kim RB, Garg AX. Digoxin dosing and the risk of toxicity in older adults with CKD. Am J Kidney Dis. 2022, 79:912-7. 10.1053\/j.ajkd.2021.09.024","journal-title":"Am J Kidney Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.02.077","article-title":"Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients","volume":"54","author":"Sampat U","year":"2009","unstructured":"Sampat U, Varadarajan P, Turk R, Kamath A, Khandhar S, Pai RG. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol. 2009, 54:452-7. 10.1016\/j.jacc.2009.02.077","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.035","article-title":"Beta-blockers in the treatment of aortic regurgitation a new opportunity?","volume":"54","author":"Elkayam U","year":"2009","unstructured":"Elkayam U. Beta-blockers in the treatment of aortic regurgitation a new opportunity?. J Am Coll Cardiol. 2009, 54:458-9. 10.1016\/j.jacc.2009.04.035","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation - a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation - a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024, 149:e1-e156. 10.1161\/CIR.0000000000001193","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.12.060","article-title":"Clinical and pharmacological effects of apixaban dose adjustment in the ARISTOTLE trial","volume":"75","author":"Zeitouni M","year":"2020","unstructured":"Zeitouni M, Giczewska A, Lopes RD, et al.. Clinical and pharmacological effects of apixaban dose adjustment in the ARISTOTLE trial. J Am Coll Cardiol. 2020, 75:1145-55. 10.1016\/j.jacc.2019.12.060","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.841437","article-title":"Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery","volume":"121","author":"Lee DH","year":"2010","unstructured":"Lee DH, Buth KJ, Martin BJ, Yip AM, Hirsch GM. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation. 2010, 121:973-8. 10.1161\/CIRCULATIONAHA.108.841437","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0652","article-title":"Preoperative frailty assessment and outcomes at 6 months or later in older adults undergoing cardiac surgical procedures: A systematic review","volume":"165","author":"Kim DH","year":"2016","unstructured":"Kim DH, Kim CA, Placide S, Lipsitz LA, Marcantonio ER. Preoperative frailty assessment and outcomes at 6 months or later in older adults undergoing cardiac surgical procedures: A systematic review. Ann Intern Med. 2016, 165:650-60. 10.7326\/M16-0652","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood K","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005, 173:489-95. 10.1503\/cmaj.050051","journal-title":"CMAJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21037\/acs-2021-taes-71","article-title":"Endovascular repair of the ascending aorta: The last frontier","volume":"11","author":"Preventza O","year":"2022","unstructured":"Preventza O, Le Huu A, Olive J, Cekmecelioglu D, Coselli JS. Endovascular repair of the ascending aorta: The last frontier. Ann Cardiothorac Surg. 2022, 11:26-30. 10.21037\/acs-2021-taes-71","journal-title":"Ann Cardiothorac Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2024.10.041","article-title":"Sealing zone failures and durability of endovascular aneurysm repair: Is it time to update instructions for use, extend repairs, or change follow up protocols?","volume":"69","author":"Spath P","year":"2025","unstructured":"Spath P, van den Berg JC. Sealing zone failures and durability of endovascular aneurysm repair: Is it time to update instructions for use, extend repairs, or change follow up protocols?. Eur J Vasc Endovasc Surg. 2025, 69:248-9. 10.1016\/j.ejvs.2024.10.041","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/533682-a-conservatively-managed-giant-ascending-aortic-aneurysm-presenting-with-new-atrial-fibrillation-and-heart-failure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:27:08Z","timestamp":1789799228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/533682-a-conservatively-managed-giant-ascending-aortic-aneurysm-presenting-with-new-atrial-fibrillation-and-heart-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.116519","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}